Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-08

FDA Approved: GUANFACINE HYDROCHLORIDE — Original Application (TWi Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved guanfacine hydrochloride as an Original Application (ANDA) submission by TWi Pharmaceuticals, Inc., establishing a generic version of the drug. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine hydrochloride (guanfacine)

Snippet

ORIG AP for GUANFACINE HYDROCHLORIDE (GUANFACINE)